univstats

Increasing Immediate Engagement and Retention in HIV Treatment with Substance Users (R01- Clinical Trials Required) - Federal Grants

Funding Opportunity Overview

Increasing Immediate Engagement and Retention in HIV Treatment with Substance Users (R01- Clinical Trials Required) is a Discretionary grant funded by National Institutes of Health. It is categorized in Health. The grants is open to all (government, organization, and/or individual) entities. The application deadline (close date) to apply is 2022-08-11 (-46 days left).
The following table summarizes the Increasing Immediate Engagement and Retention in HIV Treatment with Substance Users (R01- Clinical Trials Required) opportunity.
Opportunity NumberRFA-DA-23-002
Opportunity TitleIncreasing Immediate Engagement and Retention in HIV Treatment with Substance Users (R01- Clinical Trials Required)
Opportunity CategoryDiscretionary
Funding Instrument TypeGrant
Post DateApril 6, 2022 (Wednesday)
Last Updated DateApril 6, 2022 (Wednesday)
Close DateAugust 11, 2022 (Thursday)

Funding Detail Description

oEnsuring all PLWH have rapid access to care, especially in resource-limited settings, remains a key challenge to the success of HIV care/treatment efforts. Same day or other rapid treatment initiation may be available, but patients may be concerned that other needs will make treatment difficult or they may face delays related to the enrollment process for treatment support mechanisms (e.
g., ADAP, Ryan White, Medicaid). Similarly, long-term retention in HIV care and sustained achievement of viral suppression can be challenging even when ARV is introduced at or close to HIV diagnosis. Existing practices such as Strengths-Based Case Management and Patient Navigation often demonstrate a lack of efficacy among people with SUD.
Persons with SUD and HIV often present clinical complexities and engagement with multiple services may be necessary; where reducing and eliminating barriers (i.e. structural or individual) to immediate linkage to care is critical to minimizing time between diagnosis and treatment and can lead to achieving Ending the Epidemic goals.
Even with rapid ARV uptake, this population may need additional supports to remain continuously engaged in care. There is a need to develop and test evidence-based interventions at the systemic, organizational, and/or provider levels that can reduce the time between diagnosis and treatment while also retaining persons with SUD in HIV and SUD care.

Dates and Awards Details

The following table shows the dates and awards information in detail for Increasing Immediate Engagement and Retention in HIV Treatment with Substance Users (R01- Clinical Trials Required) federal grants. It posted on 2022-04-06 and will be closed on 2022-08-11.
Agency NameNational Institutes of Health
Important Dates
Post DateApril 6, 2022 (Wednesday)
Close DateAugust 11, 2022 (Thursday)
Last Updated DateApril 6, 2022 (Wednesday)
Archive DateSeptember 16, 2022 (Friday)
Awards DetailNot Available
Cost Sharing or Matching RequirementNo
Additional Information URLhttp://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-002.html

CFDA Numbers

The next CFDA (Catalog of Federal Domestic Assistance) numbers are associated to this federal grant.
  • 93.279 - Drug Abuse and Addiction Research Programs

Categories of Funding Activities

  • Education
  • Health
  • No Additional Explanation Reported

Funding Eligibility

Eligible Applicants:
  • State governments
  • Additional Information: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Grantor Contact Information

Grantor DetailNIH OER Webmaster
OERWebmaster03@od.nih.gov
EmailOERWebmaster03@od.nih.gov
(See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.)